Table 1 Demographics and baseline characteristics of patients ( n = 28)
From: Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis
Age (years) | 69.5 (61.5 to 75.25) |
Male gender | 25 (89.29%) |
Body mass indexa | 27.7 ± 7.1 |
APACHE II scoreb | 22.5 ± 6.5 |
Septic shock | 21 (75%) |
Duration of ventilation (days) | 20.5 ± 13.7 |
Days of stay on ICU | 35.1 ± 71.3 |
Days of stay on ICU before sepsis | 3.0 ± 4.7 |
Renal replacement therapy | 12 (42.86%) |
Days with renal replacement therapy | 4.4 ± 7.8 |
Days with vasopressors | 11.14 ± 9.55 |
Days with sedation | 8.9 ± 8.7 |
Cumulative doses | |
Midazolam (mg) | 6,930.3 ± 1,153.8 |
Propofol (mg) | 10,784.8 ± 13,749.6 |
Ketamine (mg) | 11,52.1 ± 3,347.1 |
Clonidine (μg) | 1,506.4 ± 4,118.7 |
Days with opioids | 8.9 ± 8.8 |
Cumulative doses | |
Sufentanyl (mg) | 14.9 ± 25.0 |
Morphine (mg) | 233.0 ± 147.9 |
Preexisting conditionsc | |
History of diabetes | 9 (32.1%) |
Heart failure | 7 (25.0%) |
Cerebrovascular disease | 10 (35.7%) |
Renal dysfunction | 4 (14.3%) |
Chromic obstructive pulmonary disease | 4 (14.3%) |
Liver cirrhosis | 1 (3.6%) |
History of cancer | 3 (10.7%) |
Immunosuppression | 2 (7.1%) |
Recent surgical history | |
Elective surgery | 1 (3.6%) |
Emergency surgery | 6 (21.4%) |
No history of surgery | 21 (75.0%) |
Site of infection | |
Pneumonia | 13 (46.4%) |
Abdomen | 6 (21.4%) |
Tracheobronchitis | 3 (10.7%) |
Urosepsis | 3 (10.7%) |
Meningitis | 1 (3.6%) |
Wound infection | 1 (3.6%) |
Cerebral empyema | 1 (3.6%) |
Hospital mortality | 10 (35.7%) |